Provider review
Kin Meds review
Its "$149" headline is the brand-name tier — compounded pricing is actually higher
Kin Meds' $149/month headline is the entry price for brand-name options (Wegovy, Zepbound, Foundayo) rather than the compounded line, which actually starts higher — $199/month for semaglutide and $249/month for tirzepatide. That inversion — the cheapest-looking number belonging to the brand-name tier, not the compounded one — is the opposite of the usual pattern on this list and worth reading past the headline for. On disclosure, Kin Meds is unusually direct about its own role: it identifies itself as the intake platform and names a licensed third-party pharmacy as the actual dispenser, rather than blurring the two — though that pharmacy itself is not named.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Kin Meds is a LegitScript-verified telehealth platform whose $149/month headline is the entry price for brand-name GLP-1s (Wegovy, Zepbound, Foundayo), not compounded medication — compounded semaglutide actually starts at $199/month and tirzepatide at $249/month, both higher than the advertised headline. It's unusually clear that it is an intake platform working with a separate, licensed third-party pharmacy as dispenser, rather than presenting itself as the pharmacy — though that partner pharmacy is not named. Beyond weight loss it bundles a longevity menu: sermorelin, NAD+, glutathione, TRT, and hair/skin/sexual health. No legal entity name, state of incorporation, or per-state availability list was found in the sources read.
Kin Meds is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You specifically want brand-name Wegovy, Zepbound, or Foundayo and the $149/mo figure applies to you
- You value a provider that's explicit about being an intake platform working with a separate pharmacy, rather than blurring that line
- You want a broader longevity/wellness menu (TRT, NAD+, hair/skin) alongside GLP-1
Look elsewhere if
- You assumed the $149/mo headline applied to compounded medication — it doesn't; compounded starts at $199/mo
- You want the third-party dispensing pharmacy named, not just its existence disclosed
- You want a legal entity name and state of incorporation published before enrolling
What it actually costs
What they advertise
"$149/mo" headline entry pricing, per kinmeds.com — this is the brand-name (Wegovy/Zepbound/Foundayo) tier.
What you actually pay, month to month
Compounded semaglutide actually starts at $199/mo and compounded tirzepatide at $249/mo — both higher than the $149/mo headline, which belongs to the brand-name tier instead.
The commitment trap
The advertised $149/mo headline is the brand-name-drug entry price, not the compounded price; a reader assuming otherwise would expect the wrong tier.
Checked live on Kin Meds's own site at https://kinmeds.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Kin Meds bundles in, and what it does not.
Clinician consult
A licensed-provider consult is part of enrolling, per the…
homepage.
Bloodwork / labs
Not addressed in the sources read.
Follow-ups and dose changes
Not addressed with a specific cadence in the sources read.
Human support
Not itemized beyond the provider consult in the sources read.
Injection supplies
Not itemized in the sources read.
Shipping
Not addressed with specific terms in the sources read.
Pharmacy, labs and oversight
The pharmacy
Kin Meds explicitly identifies itself as the intake platform and names a licensed third-party pharmacy as the dispenser, without naming that pharmacy specifically.
Oversight
A licensed-provider consult is part of enrolling, per the homepage. Not addressed with a specific cadence in the sources read.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Not published as a list in the sources read.
The honest cons
The part they would rather you skipped
The $149/mo headline that draws readers in is the brand-name-drug tier, not the compounded price most competitors on this list lead with — the compounded line most readers are actually comparison-shopping for starts $50-100 higher.
- Advertised $149/mo headline is the brand-name tier, not compounded — compounded starts at $199/mo
- Third-party dispensing pharmacy's identity disclosed but not named
- No legal entity name or state of incorporation disclosed
- Per-state availability not published
None of this is unique to Kin Meds — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that board ranks them. Kin Meds is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- BHBodybuilding Health+One of the deepest peptide catalogues here, and the loosest one
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Direct MedsThe plainest price mechanics on either board, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
7 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Kin Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Kin Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.